313 related articles for article (PubMed ID: 8778595)
1. Treatment of rheumatoid arthritis.
Zurier RB; DeMarco DM; Liu NY
N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
[No Abstract] [Full Text] [Related]
2. Treatment of rheumatoid arthritis.
Stohl W; Arkfeld DG
N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
[No Abstract] [Full Text] [Related]
3. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
4. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
[No Abstract] [Full Text] [Related]
5. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
[TBL] [Abstract][Full Text] [Related]
6. The changing face of rheumatoid arthritis therapy: results of serial surveys.
Mikuls TR; O'Dell J
Arthritis Rheum; 2000 Feb; 43(2):464-5. PubMed ID: 10693890
[No Abstract] [Full Text] [Related]
7. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
Rantalaiho VM; Kautiainen H; Korpela M; Hannonen PJ; Leirisalo-Repo M; Möttönen T;
Ann Rheum Dis; 2013 May; 72(5):786-8. PubMed ID: 23349132
[No Abstract] [Full Text] [Related]
8. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
Furst DE
Clin Exp Rheumatol; 1999; 17(1):39-40. PubMed ID: 10084027
[No Abstract] [Full Text] [Related]
9. [The goal for the treatment of rheumatoid arthritis should be remission].
Möttönen T; Mäkinen H; Puolakka K
Duodecim; 2010; 126(12):1457-64. PubMed ID: 20617749
[TBL] [Abstract][Full Text] [Related]
10. Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis.
BMJ; 2013 Jun; 346():f3846. PubMed ID: 23778977
[No Abstract] [Full Text] [Related]
11. Rheumatoid arthritis: new developments in the use of existing therapies.
O'Dell JR; Scott DL
Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():24-6. PubMed ID: 10646486
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis.
Emery P; Suarez-Almazor M
Clin Evid; 2003 Jun; (9):1349-71. PubMed ID: 15366179
[No Abstract] [Full Text] [Related]
13. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
Shiroky JB
J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057
[TBL] [Abstract][Full Text] [Related]
14. Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
Ganu MA; Ganu AS
J Assoc Physicians India; 2011 Feb; 59():83-6. PubMed ID: 21751641
[TBL] [Abstract][Full Text] [Related]
15. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
[No Abstract] [Full Text] [Related]
16. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
O'Dell JR
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying antirheumatic drugs.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
[No Abstract] [Full Text] [Related]
18. Rheumatoid arthritis--changing theories and treatment modalities.
van de Putte LB; van Riel PL
Acta Orthop Scand Suppl; 1995 Oct; 266():10-3. PubMed ID: 8553835
[No Abstract] [Full Text] [Related]
19. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
20. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
